{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:36:03Z","timestamp":1767591363124,"version":"3.48.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Fertility preservation (FP) and adequate counseling are crucial for young breast cancer patients in the early setting. We provide a brief summary of FP in young breast cancer patients, including current international guidelines, available FP treatments, and the safety of pregnancy. This review explores embryo\/oocyte cryopreservation, ovarian tissue cryopreservation (OTC), and gonadotropin-releasing hormone agonists (GnRHa), along with evidence on temporary endocrine therapy interruption to attempt pregnancy. Despite strong recommendations, FP uptake remains low, underscoring the need for timely multidisciplinary counseling. Literature data underline that pregnancy can be considered after treatment, even for hormone receptor-positive and BRCA mutation-positive patients. Reproductive planning should be integrated into the oncologic treatment, balancing oncologic priorities with patients\u2019 reproductive desires.<\/jats:p>","DOI":"10.3389\/fendo.2025.1695667","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:32:04Z","timestamp":1767591124000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Fertility in early breast cancer patients: integrating reproductive planning into oncology care"],"prefix":"10.3389","volume":"16","author":[{"given":"Antonella","family":"Turla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bellicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Spada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Mandruzzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"04142","DOI":"10.7189\/jogh.14.04142","article-title":"Global burden and attributable risk factors of breast cancer in young women: historical trends from 1990 to 2019 and forecasts to 2030 by sociodemographic index regions and countries","volume":"14","author":"Yuan","year":"2024","journal-title":"J Glob Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2007.07.029","article-title":"Fertility and adjuvant treatment in young women with breast cancer","volume":"16","author":"Partridge","year":"2007","journal-title":"Breast"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02782","article-title":"Fertility preservation in people with cancer: ASCO guideline update","volume":"43","author":"Su","year":"2025","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines\u2020","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26459","article-title":"Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer","volume":"118","author":"Letourneau","year":"2012","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2013.03.014","article-title":"Antim\u00fcllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer","volume":"99","author":"Anderson","year":"2013","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/jayao.2020.0012","article-title":"Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the pediatric initiative network risk stratification system","volume":"9","author":"Meacham","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00575","article-title":"Impact of taxanes, endocrine therapy, and deleterious germline BRCA mutations on anti-m\u00fcllerian hormone levels in early breast cancer patients treated with anthracycline- and cyclophosphamide-based chemotherapy","volume":"9","author":"Lambertini","year":"2019","journal-title":"Front Oncol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41523-021-00307-8","article-title":"Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer","volume":"7","author":"Poorvu","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"B10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jnci\/djy094","article-title":"Adjuvant anti-HER2 therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients","volume":"111","author":"Lambertini","year":"2019","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12609-025-00571-8","article-title":"Impact of breast cancer systemic therapies on fertility","volume":"17","author":"Hundal","year":"2025","journal-title":"Curr Breast Cancer Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-020-05933-7","article-title":"Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer","volume":"185","author":"Goldfarb","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02514","article-title":"Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2\u2013, node-positive, high-risk, early breast cancer (monarchE)","volume":"38","author":"Johnston","year":"2020","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2305488","article-title":"Ribociclib plus endocrine therapy in early breast cancer","volume":"390","author":"Slamon","year":"2024","journal-title":"New Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2019.07.016","article-title":"Reproductive and developmental toxicity assessment of palbociclib, a CDK4\/6 inhibitor, in Sprague-Dawley rats and New Zealand White rabbits","author":"Catlin","year":"2019","journal-title":"Reprod Toxicology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa128","article-title":"The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation","volume":"35","author":"Winship","year":"2020","journal-title":"Hum Reproduction"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"New Engl J Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00484-3","article-title":"Endocrine toxicities of immune checkpoint inhibitors","volume":"17","author":"Wright","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00535","article-title":"Pregnancy after breast cancer: A systematic review and meta-analysis","volume":"39","author":"Lambertini","year":"2021","journal-title":"J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"New Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02399","article-title":"Pregnancy after breast cancer in patients with germline BRCA mutations","volume":"38","author":"Lambertini","year":"2020","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx639","article-title":"Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients","volume":"29","author":"Lambertini","year":"2018","journal-title":"Ann Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.01.104","article-title":"Perinatal complications in female survivors of cancer: a systematic review and meta-analysis","volume":"111","author":"van der Kooi","year":"2019","journal-title":"Eur J Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"New Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.esmoop.2021.100276","article-title":"Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review","volume":"6","author":"Garutti","year":"2021","journal-title":"ESMO Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17588359251346648","DOI":"10.1177\/17588359251346648","article-title":"Pregnancy after breast cancer: latest evidence and practical considerations","volume":"17","author":"Mordenfeld Kozlovsky","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19810815)48:4<876::AID-CNCR2820480403>3.0.CO;2-Q","article-title":"Clinical pharmacology of tamoxifen in patients with breast cancer: Correlation with clinical data","volume":"48","author":"Fabian","year":"1981","journal-title":"Cancer"},{"key":"B28","volume-title":"Invasive breast cancer: NCCN clinical practice guidelines in oncology (version 4.2025)","year":"2025"},{"key":"B29","volume-title":"NCCN Guidelines Version 1.2026 Adolescent and Young Adult (AYA) Oncology","year":"2025"},{"key":"B30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10147-021-02076-7","article-title":"Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2","volume":"27","author":"Tozawa","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.5694\/mja2.51751","article-title":"Australian fertility preservation guidelines for people with cancer 2022: review and recommendations","volume":"217","author":"Kieu","year":"2022","journal-title":"Med J Australia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3747\/co.22.2334","article-title":"Fertility preservation in reproductive-age women facing gonadotoxic treatments","volume":"22","author":"Roberts","year":"2015","journal-title":"Curr Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/RD9.0000000000000006","article-title":"Chinese expert consensus on clinical practice of female fertility preservation","volume":"6","author":"Li","year":"2022","journal-title":"Reprod Dev Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5653\/cerm.2017.44.4.181","article-title":"Fertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines","volume":"44","author":"Kim","year":"2017","journal-title":"Clin Exp Reprod Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2016.02.006","article-title":"Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations","volume":"199","author":"von Wolff","year":"2016","journal-title":"Eur J Obstetrics Gynecology Reprod Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.3723","article-title":"Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer","volume":"33","author":"Oktay","year":"2015","journal-title":"J Clin Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"17455065221074886","DOI":"10.1177\/17455065221074886","article-title":"Oocyte and embryo cryopreservation before gonadotoxic treatments: Principles of safe ovarian stimulation, a systematic review","volume":"18","author":"Ozcan","year":"2022","journal-title":"Women\u2019s Health (Lond)"},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2024.10.014","article-title":"Long-term safety of controlled ovarian stimulation for fertility preservation before chemotherapy treatment in patients with breast cancer","volume":"123","author":"Shapira","year":"2025","journal-title":"Fertil Steril"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-015-0544-9","article-title":"Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice","volume":"32","author":"Donnez","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"B40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12958-019-0561-0","article-title":"Fertility preservation in BRCA mutation carriers\u2014efficacy and safety issues: a review","volume":"18","author":"Zhang","year":"2020","journal-title":"Reprod Biol Endocrinology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-018-1144-2","article-title":"Transplantation of frozen-thawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort","volume":"35","author":"Gellert","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.03.008","article-title":"Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers","volume":"115","author":"Dolmans","year":"2021","journal-title":"Fertil Steril"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient\u2013level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.991","article-title":"Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial","volume":"306","author":"Del Mastro","year":"2011","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djy185","article-title":"Final analysis of the prevention of early menopause study (POEMS)\/SWOG intergroup S0230","volume":"111","author":"Moore","year":"2019","journal-title":"JNCI: J Natl Cancer Institute"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1001\/jama.2015.17291","article-title":"Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival","volume":"314","author":"Lambertini","year":"2015","journal-title":"JAMA"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"New Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.breast.2019.07.001","article-title":"Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers","volume":"47","author":"Ruggeri","year":"2019","journal-title":"Breast"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-011-0328-8","article-title":"Physicians\u2019 knowledge, attitude, and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists","volume":"20","author":"Shimizu","year":"2013","journal-title":"Breast Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.14449\/jbd.2020.8.2.100","article-title":"Current practices toward fertility issues for young breast cancer patients: A survey of the korean breast cancer society; the SMARTSHIP study","volume":"8","author":"Son","year":"2020","journal-title":"J Breast Disease"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.0250","article-title":"Physician referral for fertility preservation in oncology patients: A national study of practice behaviors","volume":"27","author":"Quinn","year":"2009","journal-title":"J Clin Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.5168","article-title":"Cancer and fertility program improves patient satisfaction with information received","volume":"34","author":"Kelvin","year":"2016","journal-title":"J Clin Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.6118\/jmm.19010","article-title":"The importance of education regarding the effects of anticancer treatment on fertility and ovarian function in the female patients with breast cancer","volume":"25","author":"Shin","year":"2019","journal-title":"J Menopausal Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1089\/jayao.2017.0031","article-title":"Oncology physicians\u2019 Perspectives on practices and barriers to fertility preservation and the feasibility of a prospective study of pregnancy after breast cancer","volume":"6","author":"Rosenberg","year":"2017","journal-title":"J Adolesc Young Adult Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1001\/jamaoncol.2015.5941","article-title":"BRCA1 and BRCA2 mutation testing in young women with breast cancer","volume":"2","author":"Rosenberg","year":"2016","journal-title":"JAMA Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2017.07.001","article-title":"Fertility and pregnancy issues in BRCA -mutated breast cancer patients","author":"Lambertini","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.862733","article-title":"Comparison of the predictive capability of antral follicle count vs. the anti-M\u00fcllerian hormone for ovarian response in infertile women","volume":"13","author":"Sun","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/dev230","article-title":"Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark","volume":"30","author":"Jensen","year":"2015","journal-title":"Hum Reproduction"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac003","article-title":"Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis","volume":"28","author":"Khattak","year":"2022","journal-title":"Hum Reprod Update"},{"key":"B60","doi-asserted-by":"publisher","first-page":"hoad014","DOI":"10.1093\/hropen\/hoad014","article-title":"Extracellular matrix-derived scaffolds in constructing artificial ovaries for ovarian failure: a systematic methodological review","volume":"2023","author":"Wu","year":"2023","journal-title":"Hum Reprod Open"},{"key":"B61","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12938-025-01392-7","article-title":"Preparation and characterization of human decellularized ovarian scaffold based on supercritical carbon dioxide protocol","volume":"24","author":"Hosseinpour","year":"2025","journal-title":"BioMed Eng Online"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3390\/jcm13061791","article-title":"Comprehensive review of in vitro human follicle development for fertility restoration: recent achievements, current challenges, and future optimization strategies","volume":"13","author":"Vitale","year":"2024","journal-title":"J Clin Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.7150\/thno.97301","article-title":"Microfluidic chips in female reproduction: a systematic review of status, advances, and challenges","volume":"14","author":"Wu","year":"2024","journal-title":"Theranostics"},{"key":"B64","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s12951-024-02651-w","article-title":"Organ-on-a-chip: future of female reproductive pathophysiological models","volume":"22","author":"Deng","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e53396","DOI":"10.2196\/53396","article-title":"Harnessing artificial intelligence to predict ovarian stimulation outcomes in in vitro fertilization: scoping review","volume":"26","author":"AlSaad","year":"2024","journal-title":"J Med Internet Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"102903","DOI":"10.1016\/j.jogoh.2024.102903","article-title":"Artificial intelligence in in-vitro fertilization (IVF): A new era of precision and personalization in fertility treatments","volume":"54","author":"Olawade","year":"2025","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"B67","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.fertnstert.2015.11.027","article-title":"Oocyte vitrification as an efficient option for elective fertility preservation","volume":"105","author":"Cobo","year":"2016","journal-title":"Fertil Steril"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:32:06Z","timestamp":1767591126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":67,"alternative-id":["10.3389\/fendo.2025.1695667"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1695667","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"article-number":"1695667"}}